Alan C. Cheng

Affiliations: 
Brandeis University, Waltham, MA, United States 
Google:
"Alan Cheng"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Alan D. Frankel grad student 2002 UCSF
 (Strategies for specific recognition of RNA using hydrogen bonding.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cheng AC, Doherty EM, Johnstone S, et al. (2019) Structure-guided discovery of dual recognition chemibodies Acta Crystallographica Section A. 75
Cheng AC, Doherty EM, Johnstone S, et al. (2018) Structure-guided Discovery of Dual-recognition Chemibodies. Scientific Reports. 8: 7570
Loving KA, Lin A, Cheng AC. (2014) Structure-based druggability assessment of the mammalian structural proteome with inclusion of light protein flexibility. Plos Computational Biology. 10: e1003741
Gustin DJ, Li Y, Brown ML, et al. (2013) Structure guided design of a series of sphingosine kinase (SphK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 4608-16
Huang H, La DS, Cheng AC, et al. (2012) Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease. Journal of Medicinal Chemistry. 55: 9156-69
Bryan MC, Whittington DA, Doherty EM, et al. (2012) Rapid development of piperidine carboxamides as potent and selective anaplastic lymphoma kinase inhibitors. Journal of Medicinal Chemistry. 55: 1698-705
Liu JJ, Cheng AC, Tang HL, et al. (2011) Benzodiazepinone Derivatives as CRTH2 Antagonists. Acs Medicinal Chemistry Letters. 2: 515-8
Schenkel LB, Huang X, Cheng A, et al. (2011) Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitors. Journal of Medicinal Chemistry. 54: 8440-50
Peterson ML, Stanton MK, Kelly RC, et al. (2011) Preparation, solid state characterization, and single crystal structure analysis of N-(4-(6-(4-(trifluoromethyl)phenyl)pyrimidin-4-yloxy)benzo[d] thiazol-2-yl)acetamide crystal forms Crystengcomm. 13: 1170-1180
Cee VJ, Schenkel LB, Hodous BL, et al. (2010) Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor. Journal of Medicinal Chemistry. 53: 6368-77
See more...